Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pennisi (Catania, CT, Italy). Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study. 960

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Adherence to GOLD recommendations in Italian patients with COPD categorised as frequent and non-frequent exacerbators: The MISTRAL study Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Assessment of patients with COPD according to previous and new GOLD: Which stage in which group? Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Validation of the GOLD 2017 classification in a Chinese COPD cohort Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Late Breaking Abstract - Ten-year risk score for COPD: the NHLBI pooled cohorts study Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group Source: International Congress 2017 – Notable abstracts in asthma Year: 2017 COPD severity using GOLD 2017 in real life: The French Palomb Cohort Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Management of stable COPD: Are GOLD recommendations fully applied? Source: Annual Congress 2010 - COPD: management Year: 2010 The 2013 updated GOLD strategy: A comparison of the various scenarios Source: International Congress 2014 – Best abstracts in chronic care Year: 2014 Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017